These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 32487639

  • 1. Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis.
    Autorino R, Bisiello S, Pappalardi B, Privitera V, Buwenge M, Piccolo F, Masciocchi C, Tagliaferri L, Macchia G, Curti CD, Luppatteli M, Cerrotta A, Morganti AG, Valentini V, Mattiucci G.
    Anticancer Res; 2020 Jun; 40(6):3417-3421. PubMed ID: 32487639
    [Abstract] [Full Text] [Related]

  • 2. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
    Isayama H, Tsujino T, Nakai Y, Sasaki T, Nakagawa K, Yamashita H, Aoki T, Koike K.
    World J Gastroenterol; 2012 May 21; 18(19):2364-70. PubMed ID: 22654427
    [Abstract] [Full Text] [Related]

  • 3. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts.
    Shin HS, Seong J, Kim WC, Lee HS, Moon SR, Lee IJ, Lee KK, Park KR, Suh CO, Kim GE.
    Int J Radiat Oncol Biol Phys; 2003 Sep 01; 57(1):105-12. PubMed ID: 12909222
    [Abstract] [Full Text] [Related]

  • 4. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: is it just for palliation?
    Montemaggi P, Morganti AG, Dobelbower RR, Brizi G, Smaniotto D, Costamagna G, Cellini N, Marano P.
    Radiology; 1996 Jun 01; 199(3):861-6. PubMed ID: 8638018
    [Abstract] [Full Text] [Related]

  • 5. Combined modality treatment in unresectable extrahepatic biliary carcinoma.
    Morganti AG, Trodella L, Valentini V, Montemaggi P, Costamagna G, Smaniotto D, Luzi S, Ziccarelli P, Macchia G, Perri V, Mutignani M, Cellini N.
    Int J Radiat Oncol Biol Phys; 2000 Mar 01; 46(4):913-9. PubMed ID: 10705013
    [Abstract] [Full Text] [Related]

  • 6. A systematic review of intraluminal high dose rate brachytherapy in the management of malignant biliary tract obstruction and cholangiocarcinoma.
    Taggar AS, Mann P, Folkert MR, Aliakbari S, Myrehaug SD, Dawson LA.
    Radiother Oncol; 2021 Dec 01; 165():60-74. PubMed ID: 34695521
    [Abstract] [Full Text] [Related]

  • 7. Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma.
    Ghafoori AP, Nelson JW, Willett CG, Chino J, Tyler DS, Hurwitz HI, Uronis HE, Morse MA, Clough RW, Czito BG.
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):654-9. PubMed ID: 20864265
    [Abstract] [Full Text] [Related]

  • 8. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.
    Kocak Z, Ozkan H, Adli M, Garipagaoglu M, Kurtman C, Cakmak A.
    Radiat Med; 2005 May 01; 23(3):200-7. PubMed ID: 15940068
    [Abstract] [Full Text] [Related]

  • 9. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma.
    Montemaggi P, Costamagna G, Dobelbower RR, Cellini N, Morganti AG, Mutignani M, Perri V, Brizi G, Marano P.
    Int J Radiat Oncol Biol Phys; 1995 May 15; 32(2):437-43. PubMed ID: 7538501
    [Abstract] [Full Text] [Related]

  • 10. Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study.
    Autorino R, Mattiucci GC, Ardito F, Balducci M, Deodato F, Macchia G, Mantini G, Perri V, Tringali A, Gambacorta MA, Tagliaferri L, Giuliante F, Morganti AG, Valentini V.
    Anticancer Res; 2016 Feb 15; 36(2):737-40. PubMed ID: 26851032
    [Abstract] [Full Text] [Related]

  • 11. A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer.
    Mattiucci GC, Autorino R, Tringali A, Perri V, Balducci M, Deodato F, Gambacorta MA, Mantini G, Tagliaferri L, Mutignani M, Morganti AG.
    Brachytherapy; 2015 Feb 15; 14(3):401-4. PubMed ID: 25591935
    [Abstract] [Full Text] [Related]

  • 12. Impact of intraluminal brachytherapy on survival outcome for radiation therapy for unresectable biliary tract cancer: a propensity-score matched-pair analysis.
    Yoshioka Y, Ogawa K, Oikawa H, Onishi H, Kanesaka N, Tamamoto T, Kosugi T, Hatano K, Kobayashi M, Ito Y, Takayama M, Takemoto M, Karasawa K, Nagakura H, Imai M, Kosaka Y, Yamazaki H, Isohashi F, Nemoto K, Nishimura Y, Japanese Radiation Oncology Study Group (JROSG).
    Int J Radiat Oncol Biol Phys; 2014 Jul 15; 89(4):822-9. PubMed ID: 24969796
    [Abstract] [Full Text] [Related]

  • 13. Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study.
    Bisello S, Buwenge M, Palloni A, Autorino R, Cellini F, Macchia G, Deodato F, Cilla S, Brandi G, Tagliaferri L, Cammelli S, Valentini V, Morganti AG, Mattiucci GC.
    Anticancer Res; 2019 Jun 15; 39(6):3095-3100. PubMed ID: 31177154
    [Abstract] [Full Text] [Related]

  • 14. Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results.
    Deodato F, Clemente G, Mattiucci GC, Macchia G, Costamagna G, Giuliante F, Smaniotto D, Luzi S, Valentini V, Mutignani M, Nuzzo G, Cellini N, Morganti AG.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):483-8. PubMed ID: 16242254
    [Abstract] [Full Text] [Related]

  • 15. A Systematic Review and Meta-analysis of Intraluminal Brachytherapy Versus Stent Alone in the Treatment of Malignant Obstructive Jaundice.
    Xu X, Li J, Wu J, Zhu R, Ji W.
    Cardiovasc Intervent Radiol; 2018 Feb 01; 41(2):206-217. PubMed ID: 29075881
    [Abstract] [Full Text] [Related]

  • 16. Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duct of Wirsung.
    Mutignani M, Shah SK, Morganti AG, Perri V, Macchia G, Costamagna G.
    Endoscopy; 2002 Jul 01; 34(7):555-9. PubMed ID: 12170409
    [Abstract] [Full Text] [Related]

  • 17. Long-term survival after intraluminal brachytherapy for inoperable hilar cholangiocarcinoma: a case report.
    Chan SY, Poon RT, Ng KK, Liu CL, Chan RT, Fan ST.
    World J Gastroenterol; 2005 May 28; 11(20):3161-4. PubMed ID: 15918211
    [Abstract] [Full Text] [Related]

  • 18. Intraluminal brachytherapy in bile duct carcinomas.
    Leung J, Guiney M, Das R.
    Aust N Z J Surg; 1996 Feb 28; 66(2):74-7. PubMed ID: 8602818
    [Abstract] [Full Text] [Related]

  • 19. Intraluminal brachytherapy in the treatment of bile duct carcinomas.
    Leung JT, Kuan R.
    Australas Radiol; 1997 May 28; 41(2):151-4. PubMed ID: 9153812
    [Abstract] [Full Text] [Related]

  • 20. Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma.
    Takamura A, Saito H, Kamada T, Hiramatsu K, Takeuchi S, Hasegawa M, Miyamoto N.
    Int J Radiat Oncol Biol Phys; 2003 Dec 01; 57(5):1357-65. PubMed ID: 14630274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.